This is underscored by the results of a clinical trial comparing the development of obese adults who received either semaglutide or liraglutide in addition to nutritional advice and physical activity, and significantly greater weight loss was achieved in the semaglutide group [102]
This once-weekly GLP-1 weight loss injection effectively reduces appetite, helping you lose more weight compared to dieting alone
In SURPASS-CVOT, MOUNJARO achieved the primary objective by demonstrating a non-inferior rate of major adverse cardiovascular events (MACE-3), including cardiovascular death, heart attack or stroke vs
Sometimes anxiety, trauma, poor sleep, or depression are driving more of the concentration problem than people realize
Semaglutides consistent, scientifically proven results often provide better value for your investment
USA 111, 22472252